Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, No. 58, Zhongshan Er Road, Guangzhou, 510080, China.
Guangdong Provincial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology, Guangzhou, 510080, China.
J Physiol Biochem. 2018 May;74(2):247-260. doi: 10.1007/s13105-018-0610-8. Epub 2018 Feb 22.
Fibroblast growth factor (FGF) has been considered to modulate liver regeneration (LR) after partial hepatectomy (PH) at the tissue level. Previous studies have demonstrated that FGF15 and FGF19 induce the activation of its receptor, FGF receptor 4 (FGFR4), which can promote hepatocellular carcinoma progression and regulate liver lipid metabolism. In this study, we aimed to explore the role of the ileal FGF15/19- hepatic FGFR4 axis in the LR after PH. Male C57BL/6 mice aged 8-12 weeks were partially hepatectomized and assessed for expression of ileal FGF15/19 to hepatic FGFR4 signaling. We used recombinant human FGF19 protein and a small interfering RNA (siRNA) of FGFR4 to regulate expression of the FGF15/19-FGFR4 axis in vitro and in vivo. The proliferation and cell cycle of hepatocytes, the expression levels of FGF15/19-FGFR4 downstream molecules, liver recovery, and lipid metabolism were assessed. We found that both ileal and serum FGF15 expression were upregulated and hepatic FGFR4 was activated after PH in mice. FGF15/19 promoted cell cycle progression, enhanced proliferation, and reduced hepatic lipid accumulation of hepatocytes both in vitro and in vivo. Furthermore, the proliferative effect and lipid regulatory properties of FGF15/19 were dependent on FGFR4 in hepatocytes. In addition, ileal FGF15/19-hepatic FGFR4 transduction during hepatocyte proliferation was regulated by extracellular regulated protein kinase (ERK) 1/2. In conclusion, the ileal FGF15/19 to hepatic FGFR4 axis is activated and promotes LR after PH in mice, supporting the potential of ileal FGF15/19 to hepatic FGFR4 axis-targeted therapy to enhance LR after PH.
成纤维细胞生长因子 (FGF) 被认为在组织水平上调节部分肝切除 (PH) 后的肝再生 (LR)。先前的研究表明,FGF15 和 FGF19 诱导其受体 FGF 受体 4 (FGFR4) 的激活,这可以促进肝细胞癌的进展并调节肝脏脂质代谢。在这项研究中,我们旨在探讨回肠 FGF15/19-肝 FGFR4 轴在 PH 后 LR 中的作用。部分肝切除 8-12 周龄雄性 C57BL/6 小鼠,评估回肠 FGF15/19 对肝 FGFR4 信号的表达。我们使用重组人 FGF19 蛋白和 FGFR4 的小干扰 RNA (siRNA) 在体外和体内调节 FGF15/19-FGFR4 轴的表达。评估肝细胞的增殖和细胞周期、FGF15/19-FGFR4 下游分子的表达水平、肝恢复和脂质代谢。我们发现,在 PH 后,小鼠的回肠和血清 FGF15 表达均上调,肝 FGFR4 被激活。FGF15/19 促进细胞周期进程,增强增殖,并减少体外和体内肝细胞的肝脂质堆积。此外,FGF15/19 的增殖作用和脂质调节特性依赖于肝细胞中的 FGFR4。此外,在肝细胞增殖过程中,回肠 FGF15/19-肝 FGFR4 转导受细胞外调节蛋白激酶 (ERK) 1/2 调节。总之,回肠 FGF15/19 至肝 FGFR4 轴在小鼠 PH 后被激活并促进 LR,支持回肠 FGF15/19 至肝 FGFR4 轴靶向治疗增强 PH 后 LR 的潜力。